Does the COVID Pandemic Modify the Antibiotic Resistance of Uropathogens in Female Patients? A New Storm?

Abstract

Urinary tract infections (UTIs) represent a common pathology among female patients, leading to overprescribing antibiotics, globally. The emergence of the COVID-19 pandemic has dramatically increased the incidence of this particular viral pneumonia with secondary bacterial superinfection, resulting in continuous therapeutic or prophylactic recommendations of antibiotic treatment; thus, an updated analysis of current antimicrobial resistance among uropathogens is mandatory. This cross-sectional retrospective study conducted in two university hospitals in Bucharest, Romania analyzed 2469 positive urine cultures, among two different periods of 6 months, before and during the COVID-19 pandemic. The most common pathogen was Escherichia coli 1505 (60.95%), followed by Klebsiella spp. 426 (17.25%). Enterococcus spp. was the leading Gram-positive pathogen 285 (11.54%). In gram negative bacteria, in almost all cases, an increased in resistance was observed, but the highest increase was represented by quinolones in Klebsiella spp., from 16.87% to 35.51% and Pseudomonas from 30.3% to 77.41%; a significant increase in resistance was also observed for carbapenems. Surprisingly, a decrease in resistance to Penicillin was observed in Enterococcus spp., but the overall tendency of increased resistance is also maintained for gram positive pathogens. The lack of data on the influence of the COVID-19 pandemic on uropathogens’ resistance promotes these findings as important for every clinician treating UTIs and for every specialist in the medical field in promoting reasonable recommendations of antibiotic therapies.

Chronic Kidney Disease—An Underestimated Risk Factor for Antimicrobial Resistance in Patients with Urinary Tract Infections

“…6% in our group, ranging from 5.54% to 8.4% in other studies and Pseudomonas spp. 6% in our group, ranging from 2.59% to 7.28% in other studies [ 11 , 37 , 38 ],…”

The spectrum of bacterial infectionin a large cohort of Chinese pediatric patients with inborn errors of immunity: a nine-year, retrospective, single-center study

“…From 2020 to 2022, it has been reported that the bacterial spectrum and AMR have changed during the COVID-19 pandemic [44][45][46] . During the COVID-19 pandemic, China had many policies, including restrictions on social interaction, wearing masks, isolation, and quarantine, to reduce the spread of the virus.…”

Relationship between Biofilm-Formation, Phenotypic Virulence Factors and Antibiotic Resistance in Environmental Pseudomonas aeruginosa

“…The emergence of multidrug resistance (MDR) in bacteria has become one of the most daunting challenges of the 21st century, due to the increasing prevalence of difficult-to-treat infections and the lack of relevant therapeutic alternatives [14][15][16]. The magnitude of the issue has also been identified by political leaders, exemplified by the recent commitment of the G7 Nations to resistance surveillance and to invest in antimicrobial research [17].…”